CLINICAL_TRIALS
trial_result
· 2013-04-17
Clinical Trial Update: Entecavir for Chronic Hepatitis B Patients With Persistently Normal ALT [Phase 4]
Summary
Phase 4 clinical trial update evaluating entecavir for chronic hepatitis B patients with persistently normal ALT.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cheng-Kung University Hospital | Conditions: Chronic Hepatitis | Phase 4 | Status: UNKNOWN